AMLX — AMYLYX PHARMACEUTICALS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying AMLX?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 4 tracked investors who changed their AMLX position last quarter, 3 bought and 1 sold (75% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +3 tracked investors added or increased positions last quarter (Izzy Englander, Steve Cohen, Ken Griffin)
- +3 tracked investors reported holding AMLX at their latest filing
- −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About AMYLYX PHARMACEUTICALS INC (AMLX)
AMYLYX PHARMACEUTICALS INC (AMLX) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $38M. Across recent filings, tracked investors recorded 6 new positions, 9 increased, 12 reduced, and 5 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AMLX
How many top investors track AMLX
A small number of top investors own this.
AMLX Ownership Composition
How AMYLYX PHARMACEUTICALS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting AMLX
1 tracked investor has since exited this position — listed separately below.
- Steve CohenSep 30, 2026Point72 Asset ManagementShares388.7KValue$11.3M% Portfolio0.01%
- Ken GriffinSep 30, 2026Citadel AdvisorsShares878.4KValue$25.6M% Portfolio0.00%
- Izzy EnglanderSep 30, 2026Millennium ManagementShares191.7KValue$5.6M% Portfolio0.00%
Previously held AMLX
These investors reported AMLX in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Paul Tudor Jones | Tudor Investment Corp | 35.4K | $636K | Jun 30, 2026 |
Recent activity
- Sold$0(-100.00%)Nov 16, 2026
- $5.6MNov 16, 2026
- Increased$11.3M(2360.12%)Nov 16, 2026
- Increased$25.6M(363.80%)Nov 16, 2026
- Reduced$1.5M(-70.24%)Nov 14, 2024
- Increased$2.2M(30.08%)Feb 14, 2025
- Increased$10.9M(418.62%)May 15, 2025
- Reduced$9.7M(-50.94%)Aug 14, 2025
- Reduced$561.2K(-88.88%)Feb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- Increased$7M(38.37%)Nov 14, 2024
- Increased$10M(26.48%)May 15, 2025
- Reduced$8.3M(-54.36%)Aug 14, 2025
- Reduced$5.1M(-71.13%)Nov 14, 2025
- Sold$0(-100.00%)Feb 17, 2026
- Reduced$3.4M(-59.67%)Aug 14, 2026
- New$648Nov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- New$3.2MJul 21, 2025
- Increased$29.1M(394.70%)Aug 14, 2025
- Reduced$37.9M(-38.49%)Nov 14, 2025
- Reduced$4M(-87.99%)Feb 17, 2026
- Reduced$1.5M(-68.20%)May 15, 2026
- Reduced$283.8K(-85.17%)Aug 14, 2026
- $127.3KFeb 14, 2025
- Reduced$118.3K(-0.77%)May 15, 2025
- Reduced$77.4K(-63.88%)Aug 14, 2025
- Sold$0(-100.00%)Dec 9, 2025
- Increased$435.5K(39.87%)May 15, 2026
- Increased$636K(13.01%)Aug 14, 2026
- New$3MAug 14, 2024
- $7.1MMay 15, 2024
Frequently asked questions
- How many institutional investors hold AMLX?
- 3 tracked institutional investors disclosed a position in AMLX (AMYLYX PHARMACEUTICALS INC) in their most recent 13F filing.
- Who is the largest institutional holder of AMLX?
- Steve Cohen, Point72 Asset Management, holds the largest disclosed position in AMLX, valued at $38M.
- Did institutional ownership of AMLX increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 9 increased, 12 reduced, and 5 fully exited AMLX.
- Where does this AMLX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.